LGR5 and colorectal carcinoma: Regardless, the identification of the RevSC as the regenerative source of the LGR5+ve CSC population following chemotherapy treatment, and the role CLU has in this process, could elucidate a druggable target that may prove efficacious for the treatment of CRC.